Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

An open-label phase I study of JAK inhibitor ruxolitinib with and without CTLA-4 ig abatacept for the prophylaxis of graft-versus-host ddsease and cytokine release syndrome after T-cell replete haploidentical peripheral blood hematopoietic cell transplantation

Ramzi Abboud, Feng Gao, Maggie Nash, Jeffrey King, Samantha Bauer, Camille Abboud, Zachary Crees, Meagan Jacoby, Iskra Pusic, Mark Schroeder, Samuel Urrutia, Geoffrey Uy, John DiPersio

Blood (2025) 146 (Supplement 1): 2459.

https://doi.org/10.1182/blood-2025-2459

Published: 2025

Journal Articles

Motixafortide (CXCR4 inhibition) alone and in combination with natalizumab (VLA-4 inhibition) to mobilize hematopoietic stem cells for gene therapy in sickle cell disease: A first-in-human, safety and feasibility study

Zachary Crees, Michael Rettig, Peter Ruminski, Reyka Jayasinghe, Stephen Persaud, Stephanie Christ, Feng Gao, Hailey Sappington, Samantha Bauer, Sana Saif Ur Rehman, Suzanne Thibodeaux, Ella Sorani, Allison King, John DiPersio

Blood (2025) 146 (Supplement 1): 5956.

https://doi.org/10.1182/blood-2025-5956

Published: 2025